Zai Lab Statistics
Total Valuation
Zai Lab has a market cap or net worth of $2.87 billion. The enterprise value is $2.57 billion.
| Market Cap | 2.87B |
| Enterprise Value | 2.57B |
Important Dates
The last earnings date was Thursday, November 5, 2026, before market open.
| Earnings Date | Nov 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Zai Lab has 112.44 million shares outstanding. The number of shares has increased by 3.60% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 112.44M |
| Shares Change (YoY) | +3.60% |
| Shares Change (QoQ) | +0.58% |
| Owned by Insiders (%) | 2.17% |
| Owned by Institutions (%) | 65.31% |
| Float | 97.29M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 6.49 |
| Forward PS | 6.07 |
| PB Ratio | 5.09 |
| P/TBV Ratio | 6.03 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 5.82 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.04, with a Debt / Equity ratio of 0.47.
| Current Ratio | 2.04 |
| Quick Ratio | 1.50 |
| Debt / Equity | 0.47 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -45.16 |
Financial Efficiency
Return on equity (ROE) is -29.99% and return on invested capital (ROIC) is -19.22%.
| Return on Equity (ROE) | -29.99% |
| Return on Assets (ROA) | -15.93% |
| Return on Invested Capital (ROIC) | -19.22% |
| Return on Capital Employed (ROCE) | -46.40% |
| Weighted Average Cost of Capital (WACC) | 7.67% |
| Revenue Per Employee | $247,605 |
| Profits Per Employee | -$111,203 |
| Employee Count | 1,784 |
| Asset Turnover | 0.40 |
| Inventory Turnover | 5.76 |
Taxes
| Income Tax | -4.38M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +2.74% in the last 52 weeks. The beta is 0.72, so Zai Lab's price volatility has been lower than the market average.
| Beta (5Y) | 0.72 |
| 52-Week Price Change | +2.74% |
| 50-Day Moving Average | 24.62 |
| 200-Day Moving Average | 21.08 |
| Relative Strength Index (RSI) | 58.43 |
| Average Volume (20 Days) | 1,174,089 |
Short Selling Information
The latest short interest is 8.84 million, so 8.00% of the outstanding shares have been sold short.
| Short Interest | 8.84M |
| Short Previous Month | 7.15M |
| Short % of Shares Out | 8.00% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 10.97 |
Income Statement
In the last 12 months, Zai Lab had revenue of $441.73 million and -$198.39 million in losses. Loss per share was -$0.18.
| Revenue | 441.73M |
| Gross Profit | 2.79M |
| Operating Income | -278.26M |
| Pretax Income | -202.77M |
| Net Income | -198.39M |
| EBITDA | -261.81M |
| EBIT | -278.26M |
| Loss Per Share | -$0.18 |
Balance Sheet
The company has $559.66 million in cash and $267.45 million in debt, with a net cash position of $292.21 million or $2.60 per share.
| Cash & Cash Equivalents | 559.66M |
| Total Debt | 267.45M |
| Net Cash | 292.21M |
| Net Cash Per Share | $2.60 |
| Equity (Book Value) | 563.28M |
| Book Value Per Share | 5.01 |
| Working Capital | 440.15M |
Cash Flow
In the last 12 months, operating cash flow was -$159.21 million and capital expenditures -$4.13 million, giving a free cash flow of -$163.34 million.
| Operating Cash Flow | -159.21M |
| Capital Expenditures | -4.13M |
| Depreciation & Amortization | 16.44M |
| Net Borrowing | 37.82M |
| Free Cash Flow | -163.34M |
| FCF Per Share | -$1.45 |
Margins
Gross margin is 0.63%, with operating and profit margins of -62.99% and -44.91%.
| Gross Margin | 0.63% |
| Operating Margin | -62.99% |
| Pretax Margin | -45.90% |
| Profit Margin | -44.91% |
| EBITDA Margin | -59.27% |
| EBIT Margin | -62.99% |
| FCF Margin | n/a |
Dividends & Yields
Zai Lab does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -3.60% |
| Shareholder Yield | -3.60% |
| Earnings Yield | -0.70% |
| FCF Yield | -5.70% |
Analyst Forecast
The average price target for Zai Lab is $34.13, which is 33.95% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $34.13 |
| Price Target Difference | 33.95% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 12 |
| Revenue Growth Forecast (3Y) | 15.61% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Zai Lab has an Altman Z-Score of -0.65 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.65 |
| Piotroski F-Score | 1 |